Glucosamine for dogs: what do we actually know, and what should you look for on the label?

Glucosamine is one of the best-known supplements used to support canine joints. It can be found in tablets, powders, complex joint formulas and sometimes together with chondroitin. At the same time, precursors and structural components related to glucosamine occur naturally in cartilage and connective tissue, while green-lipped mussel contains a whole range of compounds that are of interest from a joint-health perspective.

But does glucosamine actually work?

There is no honest answer that is simply “yes” or “no”.

A much better question is: which form of glucosamine are we talking about, for what purpose, in what product, at what dose, and in what kind of dog?

Because a joint does not exist in a vacuum. And it does not live in a tub of powder either.

What is glucosamine, anyway?

Glucosamine is an amino sugar that occurs naturally in the body and is found, among other places, in the structures of cartilage and other connective tissues. Chondroitin sulfate belongs to the group of glycosaminoglycans, or GAGs, and is also a component of the extracellular matrix of cartilage.

Laboratory and preclinical studies have associated glucosamine and chondroitin with a number of mechanisms that could influence cartilage metabolism and inflammatory processes.

But an important distinction has to be made here.

A biologically plausible mechanism does not automatically mean that a substance improves pain, mobility or joint function in a real dog. For that, we need clinical studies.

And that is where the picture becomes much more mixed.

What do studies in dogs show?

Clinical results for glucosamine and chondroitin in canine osteoarthritis have been inconsistent.

In a well-known 2007 study, dogs receiving a combination of glucosamine hydrochloride and chondroitin improved in some clinical measures. The difference became clearer only after several weeks, at around day 70.

That is one reason why it makes little sense to judge glucosamine after only a few days or one week.

At the same time, later and more tightly controlled studies have also produced negative results.

In a 2023 placebo-controlled study, canine movement was assessed using, among other tools, an objective force plate. The glucosamine hydrochloride and chondroitin combination did not improve the measured locomotion parameter compared with placebo, while some of the other interventions did show improvement.

Systematic reviews have also been fairly sceptical about glucosamine and chondroitin, particularly when the question is relief of osteoarthritis-related pain.

One reasonably strong conclusion can therefore be drawn: based on current research, glucosamine cannot be regarded as a reliably proven pain reliever for canine osteoarthritis.

But that does not automatically justify a second statement: “glucosamine does absolutely nothing”.

Those are not the same conclusion.

Why can study results differ?

One problem is that the word “glucosamine” creates the impression that we are talking about one clearly defined product.

In reality, products may contain different forms of glucosamine, different amounts, and very different combinations of ingredients.

One product may contain glucosamine hydrochloride. Another may contain glucosamine sulfate. A third may combine glucosamine with chondroitin. A fourth may also contain MSM, collagen, hyaluronic acid, omega-3 or green-lipped mussel.

Pharmacokinetic studies in dogs also show that orally administered glucosamine is absorbed, but bioavailability and the concentrations achieved in the body can depend on the specific formulation.

This means that the results of a study on one particular formulation cannot automatically be applied to every product with the word “glucosamine” on the label.

The result also depends on what a study actually measures.

A veterinarian’s assessment? The owner’s assessment? A pain score? How easily the dog can stand up? Or the objective force with which the dog loads a limb?

These measures can paint different pictures.

Glucosamine does not only live in a supplement tub

When we talk about glucosamine and cartilage support, another interesting question arises. Why do we almost always talk about a capsule or powder?

Cartilage and connective tissue are natural parts of real animal tissue.

Trachea, joint cartilage, cartilage-rich chews, chicken feet, duck feet and other connective-tissue-rich animal foods do not provide only one isolated compound. They contain a whole biological matrix: cartilage components, collagen and other proteins, and depending on the tissue, minerals and other compounds as well.

That does not mean that we can calculate a specific therapeutic dose of glucosamine from one chicken foot.

We cannot reliably say how many milligrams of glucosamine a dog gets from one trachea or from 100 grams of cartilage. Composition depends on the animal species, the tissue, water content, processing and the individual product.

Nor do we currently have good clinical evidence showing that glucosamine or GAGs obtained from whole foods necessarily work better than a standardised supplement.

They are simply two different approaches.

Whole foods provide a complex food matrix. A standardised supplement makes it possible to know how much of a specific compound the dog receives.

Both can have a place.

“Like treats like” and the traditional perspective

There is another perspective within integrative veterinary medicine.

Integrative veterinarian Judy Morgan has discussed the principle of “like treats like” in the context of Traditional Chinese Veterinary Medicine and other traditional healing philosophies.

Put simply, the idea is that specific animal tissues are used in food to support the corresponding tissues in the body: heart to support the heart, liver for the liver, and cartilage, joints and connective-tissue-rich animal parts for joints and connective tissue.

This should be treated exactly for what it is: part of a traditional and integrative nutritional philosophy.

It is not a mechanism proven by a randomised clinical trial showing that eating cartilage treats osteoarthritis.

At the same time, the nutritional value of whole food does not disappear simply because its traditional explanation is different from the language of modern biomedicine.

These two questions simply need to be kept separate.

Green-lipped mussel is a world of its own

Green-lipped mussel, Perna canaliculus, is sometimes put in the same box as glucosamine.

In reality, it is not simply “natural glucosamine”.

Green-lipped mussel is a complex biological material containing a variety of lipids, proteins, glycosaminoglycans and other compounds.

Green-lipped mussel preparations have been studied in several clinical trials in dogs, and some of them have shown improvements in measures related to osteoarthritis pain, mobility or limb function.

But here, too, we need to look at what exactly was studied.

A specific green-lipped mussel lipid extract is not the same thing as dried and ground green-lipped mussel meat.

The results of one formulation cannot automatically be transferred to another simply because both come from the same mussel.

Where does Arthro Elastina fit in?

Winner Plus Arthro Elastina is a good example of why joint formulas should not be judged only by the question: “How many milligrams of glucosamine are in this?”

The product is based on New Zealand green-lipped mussel, and the manufacturer describes it as containing, among other things, glycosaminoglycans and chondroitin sulfate.

However, the manufacturer does not provide a standardised daily milligram amount of GAGs or chondroitin that would allow a direct one-to-one comparison with, for example, a glucosamine-chondroitin preparation used in a clinical study.

It is therefore more accurate to consider Arthro Elastina a complex green-lipped-mussel-based joint-support product rather than a standardised glucosamine supplement.

Likewise, the clinical results of a particular concentrated green-lipped mussel extract cannot automatically be applied to Arthro Elastina.

That does not mean Arthro Elastina does not work. It means that we should not attribute the results of a study using a different formulation to this product.

What do integrative veterinarians say?

One interesting feature of integrative veterinary approaches is that glucosamine is rarely the only thing being discussed.

Judy Morgan considers glucosamine, chondroitin, green-lipped mussel, collagen and bone broth alongside body weight, omega-3 fatty acids and regular low-impact movement.

Peter Dobias strongly favours a whole-food approach and uses green-lipped mussel and other sources of glycosaminoglycans for joint support, while also using glucosamine and chondroitin when appropriate.

Katie Woodley likewise emphasises a layered approach: whole foods, omega-3, targeted joint-support compounds, movement and rehabilitation.

Karen Becker also presents joint support as multimodal and may include glucosamine, green-lipped mussel, MSM and other supplements together with physical therapy and movement.

These are clinical approaches used within integrative veterinary medicine. They are not all supported equally by randomised controlled trials. But that does not make them nonexistent.

And this is where conventional and integrative medicine come surprisingly close together. In the end, both arrive at the same dog.

Body weight matters

In a dog with joint disease, body weight is not only about how many extra kilograms the joint has to carry.

Adipose tissue is metabolically active, and excess body fat also influences the body through inflammatory signalling.

In overweight dogs with osteoarthritis, weight loss can improve mobility and reduce lameness. For some dogs, losing a few kilograms may therefore have a greater impact on function than adding yet another supplement.

Muscle matters

A joint is not stabilised only by bones, cartilage and ligaments. Muscles are part of the system too.

When a dog is in pain, it moves less. When it moves less, it loses muscle. As muscle strength declines, the joint has less dynamic stability and movement may become even more difficult.

A vicious circle develops: pain, less movement, muscle loss, poorer function, even harder movement.

The goal with an osteoarthritic dog is therefore not simply to “protect the joint” by avoiding movement as much as possible. We also need to preserve the dog’s ability to use that joint.

Why does a joint need to move?

Articular cartilage does not have its own blood-vessel network in the way many other tissues do.

The movement of nutrients and metabolic products through cartilage depends to a large extent on synovial fluid, diffusion, and cycles of loading and unloading.

As a joint moves, pressure on the cartilage changes. In that sense, cartilage behaves a little like a sponge: alternating loading and release helps fluid and dissolved substances move through the tissue.

Synovial fluid and its components also help reduce friction between joint surfaces.

This means that physiological movement is not the enemy of cartilage.

Studies in dogs have also linked moderate exercise with changes in synovial fluid and cartilage properties.

That does not mean “the more running, the more cartilage”. Excessive or poorly chosen loading can aggravate a painful joint. But complete avoidance of movement is not a good solution either.

The goal is to find a level of activity that allows the individual dog’s joints to move, muscles to work, and the dog to recover without a clear worsening of symptoms.

FendaF’s own experience with movement

For us, this is not only a theoretical question.

My first German Shepherd, Bemmu, had cartilage in his right stifle that was essentially completely worn away. One orthopaedic specialist recommended restricting his movement very heavily. Another looked at the imaging results and said, in effect, that based on those images the dog should barely be able to move normally. Then he looked at the dog himself. The dog moved like a healthy dog.

In our case, very consistent movement worked well. We walked every day or every other day, often around 4–5 kilometres, as much as he could comfortably manage.

When movement was regular, he practically did not limp at all. If there was a 3–5 day break, he might limp again after the next walk.

It is important to remember that this is the experience of one dog, not a treatment guideline.

Four to five kilometres may be completely unsuitable for another dog with osteoarthritis. The important lesson was consistency and individually appropriate loading.

Do not judge the dog only during the walk. Look at him again a few hours later and the next morning.

If lameness or stiffness increases after activity, the dog has more difficulty getting up, or does not want to move the next day, the load may have been too high or the dog’s pain and condition may need to be reassessed.

Controlling pain is not a failure of an integrative approach

If a dog is in so much pain that it does not want to move, adequate pain control may be exactly what makes it possible to restore normal movement.

Integrative care does not have to mean avoiding medication at all costs.

When needed, medication, rehabilitation, weight management, movement, nutrition and supplements can all belong in the same care plan.

The goal is not to win an ideological competition. The goal is to give the dog a good quality of life so that it can move and live as well as possible.

Omega-3 deserves a separate mention

When we talk about nutritional support for joints, the clinical evidence for omega-3 fatty acids in canine osteoarthritis is stronger than the evidence for glucosamine and chondroitin.

That is why it is a little strange when a huge glucosamine programme is built for a dog with joint problems while nobody looks at body weight, muscle mass, movement or fatty-acid balance.

A joint does not care which tub had the prettiest or biggest label.

What about a growing puppy?

This becomes particularly important in large and giant breeds. These puppies grow very quickly, and it is completely understandable that an owner wants to support growing bones and joints as well as possible.

However, the strongest scientific foundation at present is not the idea that every large-breed puppy should automatically receive glucosamine.

The foundation is controlled growth rate, a lean body condition, a correctly balanced diet for growth, and age-appropriate exercise.

The balance of calcium, phosphorus and total energy intake is especially important.

In a large-breed puppy, faster growth does not mean better growth.

It is also not a good idea to add calcium and minerals independently to a puppy already eating a complete and balanced growth diet. During growth, disrupting mineral balance can itself interfere with normal skeletal development.

Integrative veterinary medicine may also use cartilage- and connective-tissue-rich animal foods, green-lipped mussel and different joint-support complexes as part of support for a growing dog.

Peter Dobias, for example, discusses rapidly growing puppies separately and may use green-lipped mussel, glycosaminoglycans, glucosamine and chondroitin as part of such support.

That is an integrative nutritional approach.

It does not prove that giving glucosamine preventively to a healthy puppy will prevent hip dysplasia or osteoarthritis later in life.

Those two ideas should not be confused.

Can puppies eat cartilage-rich foods?

As part of a balanced diet, suitable cartilage- and connective-tissue-rich animal foods or chews can be one way of giving a growing dog a complex food matrix.

But there is an important brake here.

Cartilage-rich does not mean unlimited.

With a puppy, the main concern is not that one trachea or cartilage-rich chew will suddenly provide a toxic amount of naturally occurring glucosamine.

We do not have good evidence for that kind of glucosamine or chondroitin “overdose”.

The much more realistic concern is the balance of the whole diet.

A chew is not made of glucosamine alone. It may provide energy, fat, protein and minerals, and if the product contains bone, calcium and phosphorus as well.

If unbalanced extras and treats begin to make up too much of a puppy’s daily intake, they can displace balanced growth food and alter the energy and mineral balance of the entire ration.

That is why veterinary nutrition commonly uses a rule of thumb that unbalanced treats and extras together should stay at around 10% or less of daily energy intake.

This is not a safety limit for glucosamine. It is a rule of thumb intended to protect the balance of the whole diet.

And with a large, rapidly growing puppy, it is better to be conservative than to turn the food bowl into a supplement laboratory.

More joint ingredients are not necessarily better

This may be the most important warning in the entire puppy section.

The message of this article is not: “I have a large puppy. Now I will give cartilage-rich chews, green-lipped mussel, Arthro Elastina and, just in case, a concentrated glucosamine-chondroitin product as well.”

Supporting joints does not mean stacking as many active ingredients as possible.

If a puppy gets cartilage-rich whole foods or chews, they need to be considered as part of the whole diet. If green-lipped mussel or a complex joint formula is used, look at what the dog is already receiving before adding another product. With a concentrated supplement, follow an appropriate weight-based dose rather than the idea that “a little more will do a little more good”.

We have no evidence that over-insuring a healthy puppy with the largest possible amount of glucosamine and chondroitin will give it better joints in the future.

Prevention does not mean maximising the quantity of joint compounds.

For a large-breed puppy, prevention means above all a normal growth rate, lean body condition, balanced nutrition and age-appropriate movement.

Cartilage-rich whole foods or a thoughtfully chosen supplement can have a place on top of that foundation within an integrative approach.

The key word is “or”, not “and, and, and, and”.

So how should you try glucosamine?

Start by looking at the product.

Which form of glucosamine does it contain? How much does the dog receive in the daily dose? Does it also contain chondroitin, MSM, collagen, hyaluronic acid, omega-3 or green-lipped mussel? Does the manufacturer even state how much of the active compounds the dog receives?

Then choose a few concrete measures before you start.

How quickly does the dog get up? Does it move freely on stairs? Does it jump into the car? How long a walk can it do comfortably? Is there stiffness after rest? When does lameness appear?

If possible, record a video of the dog in the same situation before starting and repeat it a few weeks later.

That makes it much easier to assess a real change instead of relying on the feeling that “he seems maybe a little better”.

And give the trial enough time.

In some positive glucosamine studies, the difference appeared only after several weeks. One or two weeks may be too early to draw a conclusion.

If nothing meaningful changes after an adequate trial period, it is perfectly reasonable to conclude that this particular product did not produce a noticeable benefit for this particular dog.

A supplement does not have to become a lifelong religion just because the tub has already been bought.

In summary

The clinical evidence for glucosamine in canine osteoarthritis is inconsistent.

Based on current science, it cannot be called a reliably proven pain reliever, nor can we promise that every dog will benefit from it.

At the same time, there is no reason to turn scientific uncertainty into the statement that glucosamine cannot have any role in joint support.

What matters is knowing what we are using, why we are using it and what outcome we expect.

Whole foods and cartilage-rich animal tissues can have one role. A standardised glucosamine supplement can have another. Green-lipped mussel can have a third.

For a growing puppy, there may be reasons to think about nutritional support for joints, but that does not mean stacking as many joint-support ingredients as possible.

And in a dog that already has joint problems, a supplement must not distract us from factors that may have a much bigger effect.

Appropriate body weight. Strong muscles. Regular movement that suits the dog. Balanced nutrition. Rehabilitation when needed. And pain that is not simply left to be endured.

Only on top of that foundation does it make sense to choose additional tools.

Glucosamine can be one of those tools.

But a joint does not live in a supplement tub. It lives in a dog.

Sources used

Scientific studies and guidelines

• McCarthy et al. 2007. Randomised double-blind positive-controlled trial of glucosamine/chondroitin for canine osteoarthritis.
• Kampa et al. 2023. Glucosamine/chondroitin, marine fatty acid compounds and carprofen in canine hip osteoarthritis.
• Barbeau-Grégoire et al. 2022. Systematic review and meta-analysis of enriched diets and nutraceuticals in canine and feline osteoarthritis.
• Hielm-Björkman et al. 2009. Green-lipped mussel in canine osteoarthritis.
• COAST Development Group. 2023. Canine OsteoArthritis Staging Tool treatment guidelines.
• Review: physical rehabilitation and joint physiology in canine osteoarthritis.
• FEDIAF Nutritional Guidelines.

Integrative and manufacturer sources

• Judy Morgan – TCVM food therapy and whole-food approach.
• Judy Morgan – “Like Treats Like” discussion.
• Peter Dobias – green-lipped mussel and joint support.
• WINNER PLUS Arthro-Elastina Powder – official product information.
• WINNER PLUS Arthro-Elastina Tablets – official product information.

Note: This article is educational and does not replace a veterinary assessment of an individual dog. In cases of joint disease, pain, lameness or the specific needs of a growing puppy, recommendations should be adapted to the dog’s condition and the balance of the entire diet.

---

---